Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis.
about
Epidermal Growth Factor and Intestinal Barrier FunctionRedefining the gut as the motor of critical illnessInhibition of intestinal epithelial apoptosis improves survival in a murine model of radiation combined injuryThe Gut as the Motor of Multiple Organ Dysfunction in Critical IllnessIntestine-specific deletion of microsomal triglyceride transfer protein increases mortality in aged mice.Dietary bile acid supplementation improves intestinal integrity and survival in a murine model.Can we protect the gut in critical illness? The role of growth factors and other novel approaches.Data driven linear algebraic methods for analysis of molecular pathways: application to disease progression in shock/trauma.IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis.Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis.The role of heat shock protein 70 in mediating age-dependent mortality in sepsis.Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.Epidermal growth factor improves survival and prevents intestinal injury in a murine model of pseudomonas aeruginosa pneumoniaCecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines.Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosisThe endogenous bacteria alter gut epithelial apoptosis and decrease mortality following Pseudomonas aeruginosa pneumonia.SYSTEM-WIDE MAPPING OF ACTIVATED CIRCUITRY IN EXPERIMENTAL SYSTEMIC INFLAMMATORY RESPONSE SYNDROME.Mechanisms of Intestinal Barrier Dysfunction in Sepsis.Inhibition of IKKβ in enterocytes exacerbates sepsis-induced intestinal injury and worsens mortality.Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitisMyosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.Apoptosis-induced lymphopenia in sepsis and other severe injuries.The intestinal microenvironment in sepsis.Exposure assessment of epidermal growth factor to various tissues in mice after intravenous and subcutaneous administration.Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis.Trefoil factor 1 as a marker of mucosal damage of the gastrointestinal tract in children with sepsis.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.Regulators of Intestinal Epithelial Migration in Sepsis.Epidermal Growth Factor Improves Intestinal Integrity and Survival in Murine Sepsis Following Chronic Alcohol Ingestion.Sepsis reveals compartment-specific responses in intestinal proliferation and apoptosis in transgenic mice whose enterocytes re-enter the cell cycle.G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis
P2860
Q26741547-C2576C27-428F-4FAF-B4C2-FDB34395A415Q27021300-AA069DC7-0FAE-4EAF-AC67-AA6B37B3EBE8Q27304293-B5B44BD3-D0E6-447F-8317-1499C6A3C423Q28274385-CA14C587-21B6-4C4C-A236-42E62350935CQ33882434-FB628E1B-ECED-4A1D-9D01-A9A1399599A9Q33996104-605EFBAD-8C2D-4A65-B51F-3082CD3B64B8Q34014020-F58A12DA-D706-4B44-8D1F-81FAFA33C585Q34112355-796E8FCE-66D7-4241-A485-8A2F5C386BA9Q34120958-56B5DA65-0AFA-4054-A5A1-BD9AD135C911Q34743871-8986319A-E722-4D7A-A11A-03BD6BEEDA47Q35077846-BB74A204-0C0A-4EEA-BB97-6C61F2E73DFCQ35147518-AD9EF07D-91B6-4203-AB11-17F886BE8B3AQ35218841-3448C516-79E7-4C63-8802-46A637D4F05EQ35621688-8454B71B-4C53-40C4-9E34-76E8FAB73ED3Q36082831-558EE9FF-25A6-449B-9470-4DA5B1397974Q36331146-9E913445-A306-41E1-B29B-01E4F775F5C0Q36470840-51994AA7-D94F-41D0-AE03-8523D1AC7447Q37011812-09671F69-BBD1-4B70-8CCC-BE8665DAC1DEQ37296564-3E0ED072-1B07-4835-8E17-D76E62B851E4Q37337680-323E5032-366B-434D-B055-EFF33693BDE2Q38734297-71114BF0-C350-48E6-A4B5-CA7C25C4BDC6Q38998292-A9A4E1C3-5861-42F0-888A-0FB98CE97DC2Q39175222-C064CCC1-EF89-4D9F-92C8-56FA7FE250B6Q40644552-277D8F9B-3346-4C2E-B6B6-ED65EEE8ADAEQ41264579-BE13193A-26F6-49A6-A423-B0177D1DDFB8Q44786655-7451B49E-F8DF-42F2-B97E-D31E3602846DQ47350013-26426231-0F3A-4DB3-8A1B-8C7847F88AEDQ49109102-0EEB2BEE-DBD1-4BD4-B36D-CE130C271F7FQ50051611-71537BB1-36B7-4598-9C69-2985F8A94203Q50326470-5FD1CFA7-2B6E-42CB-9FE4-6A38244A666AQ51800786-6C8E54C6-AFEE-4081-9C00-5EDD091B0ACDQ57110557-CA8290C2-0EA6-4DC0-B13A-668B71D80683
P2860
Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Epidermal growth factor treatm ...... roved gut integrity in sepsis.
@en
type
label
Epidermal growth factor treatm ...... roved gut integrity in sepsis.
@en
prefLabel
Epidermal growth factor treatm ...... roved gut integrity in sepsis.
@en
P2093
P2860
P1433
P1476
Epidermal growth factor treatm ...... proved gut integrity in sepsis
@en
P2093
Andrew T Clark
Craig M Coopersmith
Jessica A Clark
P2860
P356
10.1097/SHK.0B013E31815D0820
P577
2008-07-01T00:00:00Z